No Data
No Data
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)
Buy Rating for Phathom Pharmaceuticals Amid Strong Voquezna Prescription Growth
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Phathom Pharmaceuticals' V Oquezna: A Rising Star in GERD Treatment Market
Express News | Phathom Pharmaceuticals Inc - Prices Underwritten Offering at $11.50 per Share
Express News | Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants